SAN DIEGO, August 19, 2025 – Knobbe Martens partners Joe Reisman and Ryan Melnick serve as IP counsel to Ligand Pharmaceuticals Incorporated, a biopharmaceutical royalty aggregator.
Dr. Reisman and Dr. Melnick provided support to Ligand on IP issues relating to its private placement of $460 million aggregate principal amount of 0.75% convertible senior notes due 2030. Ligand completed the offering on August 14, 2025.
More information on the offering can be found here.
About Knobbe Martens
Knobbe Martens is a highly respected intellectual property law firm, offering legal services in all aspects of intellectual property and technology law. The firm’s litigation group handles cases throughout the U.S. and coordinates strategy for disputes worldwide. Founded in California in 1962, the firm has about 300 lawyers and scientists based in offices located in Orange County, Los Angeles, New York, San Diego, San Francisco, Seattle and Washington D.C. Knobbe Martens serves a diverse international client base, from multinational corporations to emerging businesses of all stages. More information about the firm can be found at www.knobbe.com.
Subscribe for News and Updates
